There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 1 | 27 | 214.44 |
| 1 | 21 | 214.4 |
| 1 | 34 | 214.37 |
| 1 | 77 | 214.36 |
| 2 | 18 | 214.34 |
| Ask | Qty | Orders |
|---|---|---|
| 214.54 | 1 | 1 |
| 214.55 | 4 | 66 |
| 214.59 | 2 | 48 |
| 214.6 | 2 | 6 |
| 214.61 | 1 | 1 |
Annual Revenue,rose 2,469.6%, in the last year to ₹1,890.12 Cr. Its sector's average revenue growth for the last fiscal year was 12.14%.Annual Net Profit,rose 553.48% in the last year to ₹1,553.2 Cr. Its sector's average net profit growth for the last fiscal year was 1.91%.Price to Earning Ratio,is 4.52, lower than its sector PE ratio of 46.24.
Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. The company is engaged in the pharmaceutical research and development. The company’s core focus is innovation and new product development for global markets.
SPARC undertakes projects in research and technology for new chemical entities (NCE’s) or new molecules, and novel drug delivery systems (NDDS).
For Q4 FY26, Sun Pharma Advanced Research Company Ltd reported: Revenue (Net Sales): ₹18532.20 Cr - Up 21831.60% year-on-year from ₹84.50 Cr in Q3 FY26. Net Income (PAT): ₹17607.00 Cr - Up -2285.30% year-on-year from ₹-805.70 Cr in Q3 FY26.
The intraday low for Sun Pharma Advanced Research Company Ltd on the NSE today was ₹212.25. The stock's 52-week low stands at ₹108.00, recorded on 23 Mar 2026. Today's low is 96.53% above the 52-week low, indicating the stock is trading well above its yearly lows.
Sun Pharma Advanced Research Company Ltd has delivered a return of 47.38% over the last 3 months. The stock was trading at ₹146.72 on 27 Apr 2026 and is currently at ₹214.81 as of 27 Jul 2026, reflecting a Gain of ₹68.09 per share over this period.
As of 27 Jul 2026, the share price of Sun Pharma Advanced Research Company Ltd is ₹214.81 on the NSE and ₹215.15 on the BSE. The stock opened at ₹217.49, touched a high of ₹219.10 and a low of ₹212.25 during today's session.
Over the last 6 months, Sun Pharma Advanced Research Company Ltd has given a return of 75.73%. The stock was priced at ₹123.05 on 27 Jan 2026 and has Rise to ₹214.81 as of 27 Jul 2026, a change of ₹91.76 per share.
Sun Pharma Advanced Research Company Ltd has delivered 44.18% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹289.00 on 08 Jul 2026 and a 52-week low of ₹108.00 on 23 Mar 2026. It is currently trading at ₹214.81 as of 27 Jul 2026.
The all-time high (ATH) for Sun Pharma Advanced Research Company Ltd was ₹539.98, recorded on 09 Mar 2015. At the current price of ₹214.81, the stock is trading 60.22% below its all-time high. The all-time low recorded was ₹64.97 on 10 Feb 2011.
Sun Pharma Advanced Research Company Ltd has delivered a -10.50% absolute return over the past 5 years, equivalent to a CAGR of -2.19% per annum. The stock was priced at ₹240.01 in Jul 2021 and has fallen to ₹214.81 as of 27 Jul 2026. An investment of ₹1,00,000 in Sun Pharma Advanced Research Company Ltd five years ago would be worth ₹89,500.00 today.
No,Sun Pharma Advanced Research Company Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of N/A per share between FY2022 and FY2026, with the most recent dividend of ₹N/A per share. At the current market price of ₹214.81, the trailing dividend yield of Sun Pharma Advanced Research Company Ltd stands at N/A%.
The intraday high for Sun Pharma Advanced Research Company Ltd on the NSE today (27 Jul 2026) was ₹219.10. This compares to the 52-week high of ₹289.00 recorded on 08 Jul 2026. Today's high was -24.19% below the 52-week high.
